Teva issues US recall for Cipla-manufactured fluconazole batch
This article was originally published in Scrip
Teva Pharmaceuticals USA has initiated a recall in the US of a certain batch of the antifungal fluconazole manufactured by the Indian firm, Cipla, following the possibility of a higher strength tablet being present in the 100mg packaging.
You may also be interested in...
Gland Pharma, controlled by Chinese group Fosun, makes shining debut on Indian stock markets despite a lukewarm response to its IPO. Will the buoyant market sentiment sustain amid edgy India-China relations?
A senior executive of Janssen’s supply chain leadership team outlines how the company handled activities in Asia Pacific at the height of the coronavirus outbreak, including ensuring continuous and rapid supplies of critical medicines in China. The company is also prepping against “multiple scenarios” to ensure global access for its potential COVID-19 vaccine.
Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.